1,673
Views
34
CrossRef citations to date
0
Altmetric
Research Articles

Anaplastic Large Cell Lymphoma in Children and Adolescents

, MD & , MD, PhD
Pages 509-519 | Received 08 May 2013, Accepted 11 May 2013, Published online: 12 Jun 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Maharshi Trivedi, Priyakumari Thankamony, Manjusha Nair, Binitha Rajeswari, C S Guruprasad, V R Prasanth, Rekha A. Nair & K M Jagathnath Krishna. (2023) Clinical profile and outcome of children with anaplastic large cell lymphoma treated with short-course chemotherapy – ten years experience from a tertiary care center in a LMIC. Pediatric Hematology and Oncology 40:5, pages 485-496.
Read now
Shih-Hsiang Chen, Jiann-Shiuh Chen, Shiann-Tarng Jou, Kang-Hsi Wu, Iou-Jih Hung, Jiunn-Ming Sheen, Meng-Yao Lu, Bow-Wen Chen, Tang-Her Jaing, Shih-Chung Wang, Ming-Tsan Lin, Te-Kau Chang, Hsi-Che Liu & Chao-Ping Yang. (2019) Outcome and prognosis of anaplastic large cell lymphoma in children: a report from the Taiwan Pediatric Oncology Group. Leukemia & Lymphoma 60:8, pages 1942-1949.
Read now
Dominik Karres, Daniel O’Connor, Koen Norga & Angeliki Siapkara. (2018) Drug development in pediatric oncology – challenges and opportunities – reflections from European regulators. Expert Opinion on Orphan Drugs 6:9, pages 519-526.
Read now
Chen Tian, Yong Yu, Hongliang Yang, Lei Zhu, Yafei Wang & Yizhuo Zhang. (2016) ALK-positive anaplastic large cell lymphoma with prominent bone involvement in a 13-year-old boy. OncoTargets and Therapy 9, pages 265-268.
Read now
Xueyan Chen, Lorinda A Soma & Jonathan R Fromm. (2014) Targeted therapy for Hodgkin lymphoma and systemic anaplastic large cell lymphoma: focus on brentuximab vedotin. OncoTargets and Therapy 7, pages 45-56.
Read now
Catherine M. Bollard. (2014) A Change in the Editorial Office: Farewell from Catherine M. Bollard. Pediatric Hematology and Oncology 31:5, pages 393-394.
Read now

Articles from other publishers (28)

Pritam Singha Roy, Subhalakshmi Sengupta, Ejaz A. Bari, Kousik Nandy & Aadil Adnan. (2023) Pyrites: A Mystifying Sacral Mass. Journal of Pediatric Hematology/Oncology.
Crossref
Eric J. Lowe, Anne F. Reilly, Megan S. Lim, Thomas G. Gross, Lauren Saguilig, Donald A. Barkauskas, Rui Wu, Sarah Alexander & Catherine M. Bollard. (2023) Crizotinib in Combination With Chemotherapy for Pediatric Patients With ALK+ Anaplastic Large-Cell Lymphoma: The Results of Children's Oncology Group Trial ANHL12P1. Journal of Clinical Oncology 41:11, pages 2043-2053.
Crossref
Yingyi He, Kunlin Pei, Hui Zhang, Jiayi Wang, Xiaoling Su, Wenting Gan & Pengfei Wang. (2022) Observation of Alectinib‐ and Crizotinib‐ included chemotherapy in children with ALK ‐positive anaplastic large cell lymphoma: A single institutional experience . Cancer Medicine 12:6, pages 7182-7188.
Crossref
Yu-Tong Zhang, Li-Zhe Wang & Jian Chang. (2022) Characteristics and Outcomes of Chinese Children With Advanced Stage Anaplastic Large Cell Lymphoma: A Single-Center Experience. Frontiers in Oncology 12.
Crossref
Enass H. Raffa, Helen M. Branson, Bo Ngan, Sarah Alexander & Oussama Abla. (2021) Central nervous system relapse in a child with anaplastic large cell lymphoma: potential for new therapeutic strategies. Cancer Reports 4:5.
Crossref
Eric J. Lowe, Anne F. Reilly, Megan S. Lim, Thomas G. GrossLauren SaguiligDonald A. Barkauskas, Rui Wu, Sarah Alexander & Catherine M. Bollard. (2021) Brentuximab vedotin in combination with chemotherapy for pediatric patients with ALK+ ALCL: results of COG trial ANHL12P1. Blood 137:26, pages 3595-3603.
Crossref
Maureen M. O’Brien. (2020) Defining the Optimal Treatment of First Relapse of Pediatric Relapsed Anaplastic Large-Cell Lymphoma: Clinical Trial Challenges for Rare Diagnoses. Journal of Clinical Oncology 38:34, pages 3980-3982.
Crossref
Amol Patel, Deepam Pushpam, MC Sharma, Sanjay Thulkar & Sameer Bakhshi. (2020) Predictors of Outcome in Pediatric Anaplastic Large Cell Lymphoma. Indian Pediatrics 57:6, pages 523-526.
Crossref
Zihua Zeng, Ching-Hsuan Tung & Youli Zu. (2020) Aptamer-Equipped Protamine Nanomedicine for Precision Lymphoma Therapy. Cancers 12:4, pages 780.
Crossref
Youli Zu. (2020) Aptamer technology: a new approach to treat lymphoma?. Blood Science 2:1, pages 11-15.
Crossref
Hany Abdel Rahman, Samah El Semary, Mohamed Sedky, Iman Atteya, Naglaa El Kinaaie, Madeha El Wakeel, Omneya Hassanein & Rana Mohy. (2019) Prognostic Factors and Treatment Outcome of Pediatric Anaplastic Large Cell Lymphoma Treated at the Children Cancer Hospital Egypt. Journal of Pediatric Hematology/Oncology 41:7, pages e427-e431.
Crossref
Kristen Penberthy, Joanne MendozaMichael MendozaGrant HarrisonLuke Lancaster, Brian Belyea & Steven L. Zeichner. (2019) Abdominal Pain and Intermittent Fevers in a 16-Year-Old Girl. Pediatrics 144:3.
Crossref
Adam C Wilberger & Xiayuan Liang. (2018) Primary Nonanaplastic Peripheral Natural Killer/T-Cell Lymphoma in Pediatric Patients—An Unusual Distribution Pattern of Subtypes. Pediatric and Developmental Pathology 22:2, pages 128-136.
Crossref
Mojgan Djavaheri-Mergny, Sylvie Giuriato, Mario P. Tschan & Magali Humbert. (2019) Therapeutic Modulation of Autophagy in Leukaemia and Lymphoma. Cells 8:2, pages 103.
Crossref
Eric J. Lowe & Laurence Brugieres. 2019. Non-Hodgkin's Lymphoma in Childhood and Adolescence. Non-Hodgkin's Lymphoma in Childhood and Adolescence 251 262 .
Franco Locatelli, Christine Mauz-Koerholz, Kathleen Neville, Anna Llort, Auke Beishuizen, Stephen Daw, Marta Pillon, Nathalie Aladjidi, Thomas Klingebiel, Judith Landman-Parker, Aurora Medina-Sanson, Keith August, Jessica Sachs, Kristen Hoffman, Judith Kinley, Sam Song, Gregory Song, Stephen Zhang, Ajit Suri & Lia Gore. (2018) Brentuximab vedotin for paediatric relapsed or refractory Hodgkin's lymphoma and anaplastic large-cell lymphoma: a multicentre, open-label, phase 1/2 study. The Lancet Haematology 5:10, pages e450-e461.
Crossref
Tang-Her Jaing, Tsung-Yen Chang, Shih-Hsiang Chen, Yu-Chuan Wen, Wen-Yu Chuang & Chao-Ping Yang. (2018) Small cell variant of ALK-positive anaplastic large cell lymphoma with primary subcutaneous presentation. Medicine 97:26, pages e11222.
Crossref
Soumitra Tole, Laura Wheaton & Sarah Alexander. (2018) Pediatric Anaplastic Large Cell Lymphoma—A Review. Oncology & Hematology Review (US) 14:1, pages 21.
Crossref
Julie Frentzel, Domenico Sorrentino & Sylvie Giuriato. (2017) Targeting Autophagy in ALK-Associated Cancers. Cancers 9:12, pages 161.
Crossref
Hao Chen, Jing-shu Xiong, Nan Sheng, Wen-kai Zong, Yi-hua Wang, Min Li & Jian-fang Sun. (2017) Primary Cutaneous Sarcomatoid Anaplastic Lymphoma Kinase-Positive Anaplastic Large-Cell Lymphoma With Linear Distributional Lesions. The American Journal of Dermatopathology 39:11, pages 863-866.
Crossref
Margaret Perry. (2016) Supporting and treating children with non-Hodgkin lymphoma. Practice Nursing 27:12, pages 590-596.
Crossref
Ellen M. Chung & Michael Pavio. (2016) Pediatric Extranodal Lymphoma. Radiologic Clinics of North America 54:4, pages 727-746.
Crossref
Jeong Eun KimEui Hyun OhYoung Suck RoJoo Yeon Ko. (2016) CD30-Positive Anaplastic Lymphoma Kinase-Negative Systemic Anaplastic Large-Cell Lymphoma in a 9-Year-Old Boy. Annals of Dermatology 28:3, pages 371.
Crossref
S. Carnesecchi, A.-L. Rougemont, J.H. Doroshow, M. Nagy, S. Mouche, F. Gumy-Pause & I. Szanto. (2015) The NADPH oxidase NOX5 protects against apoptosis in ALK-positive anaplastic large-cell lymphoma cell lines. Free Radical Biology and Medicine 84, pages 22-29.
Crossref
Dan Xue, Xiuzhen Li, Yunqing Ren, Qi Liu, Yun Yen & Lijun Xue. (2015) Primary Cutaneous Anaplastic Large Cell Lymphoma With Positive ALK Expression and a Rapidly Progressive Cutaneous Nodule. International Journal of Surgical Pathology 23:4, pages 333-335.
Crossref
Nahla Ali Mobark, Suha A. Tashkandi, Wafa Al Shakweer, Khalid Al Saidi, Suha A. Fataftah, Mohammed M. Al Nemer, Awatif Alanazi, Mohammed Rayis, Walid Ballourah, Othman Mosleh, Zaheer Ullah, Fahad El Manjomi & Musa Al Harbi. (2015) Pediatric Non-Hodgkin Lymphoma: A Retrospective 7-Year Experience in Children & Adolescents with Non-Hodgkin Lymphoma Treated in King Fahad Medical City (KFMC). Journal of Cancer Therapy 06:04, pages 299-314.
Crossref
Gema Mira-Perceval Juan, Pedro J. Alcalá Minagorre, Ana M. Huertas Sánchez, Sheila Segura Sánchez, Silvia López Iniesta, Francisco J. De León Marrero, Estela Costa Navarro & María Niveiro de Jaime. (2015) Cardiac Tamponade Associated with the Presentation of Anaplastic Large Cell Lymphoma in a 2-Year-Old Child. Case Reports in Pediatrics 2015, pages 1-4.
Crossref
Vasiliki Leventaki, Joseph D. Khoury & Stephan D. Voss. 2015. Pediatric Malignancies: Pathology and Imaging. Pediatric Malignancies: Pathology and Imaging 103 149 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.